Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Disease With Systemic Sclerosis”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Testing effectiveness (Phase 2)Looking for participantsNCT06619561
What this trial is testing

Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Who this might be right for
Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC 48
Not applicableLooking for participantsNCT07236970
What this trial is testing

Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic Sclerosis

Who this might be right for
Pulmonary HypertensionSystemic Sclerosis (SSc)Systemic Sclerosis-Associated PAH
Alejandro Cruz Utrilla 350
Not applicableLooking for participantsNCT05345795
What this trial is testing

Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
Central Hospital, Nancy, France 600
Large-scale testing (Phase 3)Study completedNCT00319033
What this trial is testing

Open-label Study With Bosentan in Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseScleroderma
Actelion 132
Not applicableLooking for participantsNCT07345052
What this trial is testing

Western Sweden Systemic Sclerosis Project

Who this might be right for
Scleroderma, SystemicFibrosis; SkinFibrosis Lung+1 more
Sahlgrenska University Hospital 150
Early research (Phase 1)Ended earlyNCT03656627
What this trial is testing

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Who this might be right for
Autoimmune DiseasesNon-small Cell Lung CancerRheumatoid Arthritis+7 more
Alliance Foundation Trials, LLC. 7
Not applicableUnknownNCT03560154
What this trial is testing

Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Pulmonary Fibrosis
Istanbul University 60
Early research (Phase 1)Study completedNCT03675581
What this trial is testing

Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 17
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Not applicableUnknownNCT00453752
What this trial is testing

Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Medical University of Warsaw 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02682511
What this trial is testing

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

Who this might be right for
Scleroderma, DiffuseScleroderma, SystemicScleroderma, Limited+5 more
Cumberland Pharmaceuticals 34
Testing effectiveness (Phase 2)Looking for participantsNCT06189495
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Changchun GeneScience Pharmaceutical Co., Ltd.
Testing effectiveness (Phase 2)Ended earlyNCT04837131
What this trial is testing

Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Who this might be right for
Systemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more
Michael M. Pham 4
Post-approval studies (Phase 4)Study completedNCT01042158
What this trial is testing

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis

Who this might be right for
Pulmonary Arterial HypertensionSystemic SclerosisScleroderma Spectrum of Diseases+2 more
Johns Hopkins University 25
Not applicableAvailableNCT04432545
What this trial is testing

Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Universidad de la Sabana
Not applicableUnknownNCT06105073
What this trial is testing

"Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis"

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung Disease
Coordinación de Investigación en Salud, Mexico 67
Large-scale testing (Phase 3)Study completedNCT03313180
What this trial is testing

A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 444
Testing effectiveness (Phase 2)Ended earlyNCT00581997
What this trial is testing

QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis

Who this might be right for
Pulmonary Fibrosis Secondary to Systemic Sclerosis
Novartis Pharmaceuticals 8
Not applicableLooking for participantsNCT04095351
What this trial is testing

Connective Tissue Diseases and Lung Manifestations

Who this might be right for
Connective Tissue DiseasesInterstitial Lung DiseaseSystemic Sclerosis
Medical University Innsbruck 120
Testing effectiveness (Phase 2)Study completedNCT07542067
What this trial is testing

Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Fundación Neumologica Colombiana 1
Load More Results
30